Dr Peter McCullough presents our work to the Arizona State Senate

The Covid vaccines disproportionately killed your Grandma and Grandpa

I was alerted last night to a tweet by Dr Peter McCullough (substack) regarding his testimony yesterday before the Arizona State Senate’s Novel Coronavirus South Western Intergovernmental Committee.

Our First VAERS Report

In his testimony Peter turns to discussing the work I led in April/May 2021 (available here) reviewing the entire record for the first 250 complete death reports filed against the Covid-19 vaccines in the Vaccine Adverse Event Reporting System (VAERS).

Quoting from the preprint paper we released, the process for our review of the VAERS records was:

“For each patient cited in a report, a clinically trained reviewer manually examines the report to determine its source and clinical credibility and to identify and record medical history, current illness, and symptoms. Each is then checked by a second reviewer.”

And the team who agreed to undertake this work with me:

“The reviewers and authors include people trained in clinical nursing, a medical practitioner, health informaticians, a psychologist, a chartered mathematician, and a statistician.”

In his presentation to the Senate Committee, Peter raises several points drawn from the methodology and findings of our first VAERS report that we need to remember as we reflect on the Covid-19 period.

1. Ours is the only VAERS analysis to date where the vignettes and clinical notes written by the treating clinicians were reviewed by two separate members of our team, coded, and then a process similar to the AGREE protocol was used to review and discuss the findings and agree such things as:

   1. The cause of death where the clinical description was of symptoms at death absent a clearly identified cause of death;

   2. Whether the report was more likely to have been made or authored by a clinician or someone from a clinical facility (72%), or a lay person such as a family member or friend (28%);

2. Large numbers of those who died in those early reports did so within hours or days of injection, which supports a temporal relationship between their death and the vaccines. We observed that:

   1. 50% of individuals described in the reports died within 48 hours of receiving their Covid-19 vaccine injection, and;

   2. 80% died within 7 days.

3. 34% of the total number of individuals in the early VAERS death reports we reviewed were seniors aged 85 or over, 55% were aged over 80 years, and nearly 75% were aged over 70. These were our parents and grandparents who had survived covid during almost the whole of 2020, only for many of them to succumb within 48 hours of being injected with the Covid-19 vaccines.

You can watch this portion of Peter’s testimony here:

Our Second VAERS Report

In April 2022 our team again returned to the VAERS data to update our analysis and findings one year in to the Covid-19 vaccination program. Our review and author team increased to include another doctor and a pathologist, and the number of records we reviewed in our second analysis increased 400% from 250 in the first report, to 1012.

We found that in an environment where censorship and fact-checker criticism of the VAERS data was rife and where the defined purpose or outcome for vaccination had weakened considerably, the VAERS data continued to show credible signals that all was not right with the Covid-19 vaccines.

While we incorporated the use of extensively trained and tested machine learning (ML) tools known as text classifiers (MLTC), the process for our second analysis (found here) remained rigorous and consistent with the first.

Our findings from this second cohort of VAERS reports found that:

• As the Covid-19 vaccines were rolled out sequentially to the decreasing age groups, the percentage of deaths reported in those groups were seen to increase.

  

• Disparity in the likelihood of a reported death based on gender has significantly reduced (deaths in males in the original 2021 cohort were 1.6 times more likely based on the reviewed reports)

  

• All reported deaths in minors reviewed in the 2022 cohort (those below the age of 15 years) were males, and in most age groups males were still more frequently reported.

• The majority of VAERS death reports (63%) continue to demonstrate characteristics strongly supporting that a healthcare provider was the reporting person

  

• While 31% fewer people in the 2022 cohort had reported comorbidities, the incidence of cardiac, hypertensive and diabetic comorbidities was generally consistent with the previous 2021 cohort.

• For the first time the CDC recognised the occurrence of post-vaccination breakthrough infections (where a vaccinated person becomes infected and symptomatic with the disease) which were described in the reports of almost half (49.1%) of the 2022 cohort.

• That the distribution of breakthrough infections identified in the 2022 cohort broadly matches the distribution of doses received.

Our analysis strongly suggested that administration of the vaccine to those with, at the very least, hypertensive and cardiac orders, even those who are very early in their disease progression, should be re-evaluated. Further, given the high number of diabetics in both cohorts administration to this group of people should also be reconsidered.   

We also observed that prior to their emergency use authorisation being revoked, AstraZeneca proclaimed their Covid-19 vaccine 100% effective at protecting against severe disease, hospitalisation and death¹. It is doubtful that these claims would provide any comfort to those whose family members died of Guillain-Barre Syndrome, blood clots and strokes linked to receiving the AstraZeneca Covid-19 vaccine. This does, however, raise the question of why other Covid-19 vaccines have not seen similar recalls and emergency use authorisation revocation when they too have been linked to an equal and rapidly burgeoning number of deaths – from: (i) myocarditis and heart failure; (ii) as a result of contamination during manufacture²; and (iii) acceptance by regulators that they hasten death in the elderly³.

---

Epilogue

Just like this substack, the work I and my team undertook to review and analyse the VAERS data and write the reports used in this instance by leading clinicians and academics like Dr Peter McCullough occured in our own time and using our own resources. We were not funded by any employer, institute or other entity. Shortly, we intend to commence the second annual update of the VAERS analysis. You can support that and our other ongoing work by becoming a paid subscriber to the Law, Health and Technology substack.

Acknowledgements

I would like to thank my co-authors (Magda Osman, Kuda Dube, Patience Chikatero, Yvonne Choi, Jonathan Engler, Clare Craig, Norman Fenton and Martin Neil), the other unnamed practicing doctor, nurses (x2) and midwife (who all did not want to be named for fear of reprisals from their licensing bodies), and our entire research group for their assistance and the time they freely gave to complete the work described in both VAERS reports.

1. https://www.astrazeneca.com/media-centre/press-releases/2021/covid-19-vaccine-astrazeneca-confirms-protection-against-severe-disease-hospitalisation-and-death-in-the-primary-analysis-of-phase-iii-trials.html

2. https://www.theguardian.com/world/2021/sep/07/third-person-dies-in-japan-after-taking-contaminated-moderna-coronavirus-vaccine and https://www.reuters.com/business/healthcare-pharmaceuticals/two-die-japan-after-shots-suspended-moderna-vaccines-japan-govt-2021-08-28/

3. https://7news.com.au/sunrise/on-the-show/29-norwegians-died-after-taking-pfizer-covid-jab-so-should-we-be-concerned-c-1977656 and https://www.bmj.com/content/373/bmj.n1372